Lilly investors are upbeat on injectable weight-loss treatment Mounjaro, but the pills easier to take, cheaper to make might have the biggest long-term impact.
Lilly investors are upbeat on injectable weight-loss treatment Mounjaro, but the pills easier to take, cheaper to make might have the biggest long-term impact.
Operator: Good day, and thank you for standing by. Welcome to the First Quarter 2023 Novo Nordisk A/S Earnings Conference Call. . Please be advised that this conference is being recorded.
Operator: Good day, and thank you for standing by. Welcome to the Q4 2022 Novo Nordisk A/S Earnings Conference Call. At this time, all participants are in a listen-only mode.